James Noble

Director, CURAGEN CORP.

Companies

LAVA Therapeutics NVBoard member Jan 2, 2025 to now¹
Adaptimmune (United Kingdom)Board member Jan 4, 2016 to Jul 1, 2022²
Adaptimmune (United Kingdom)Chief executive officer Jan 4, 2016 to May 17, 2019²
MELA SciencesBoard member Dec 19, 2011 to Jan 6, 2012³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLAVA Therapeutics NV, Board member
2
SEC EDGARAdaptimmune (United Kingdom), Board member
3
SEC EDGARMELA Sciences, Board member